October 01, 2020
Gilead Sciences Update on Supply and Distribution of Veklury® (remdesivir) in the United States
— Supply of Veklury Is Meeting Real-Time Demand in the U.S. —
— Clinical Benefits of Veklury Consistently Demonstrated Across Three Randomized, Clinical Trials Are Now Available to All Clinically Appropriate Hospitalized COVID-19 Patients in the U.S. —
— Veklury Distribution Has Transitioned from the U.S. Government to Gilead —
FOSTER CITY, Calif.–(BUSINESS WIRE)– Since the COVID-19 pandemic began, Gilead has worked diligently to ramp up production and rapidly expand the supply of our investigational antiviral drug Veklury® (remdesivir) by making significant investments to increase internal manufacturing capacity, expand our contract manufacturing network and implement process improvements. While working to increase our manufacturing capacity over these past months, the company also donated 1.5 million vials of Veklury and provided clinical drug supply at no cost for evaluation as an investigational agent in clinical trials around the world. As a result of the decision to make early investments to increase Veklury manufacturing efforts, Gilead is now meeting real-time demand for Veklury in the United States and anticipates meeting global demand for Veklury in October, even in the event of potential future surges of COVID-19.
Starting on October 1, Gilead will be responsible for distributing Veklury in the United States upon conclusion of the previous distribution agreement with the U.S. Federal government. To ensure stable management of drug supply in the near term, AmerisourceBergen will continue to serve as the sole U.S. distributor of Veklury through the end of this year and will sell the product directly to hospitals. This distribution model closely reflects the traditional model hospitals use to procure medicines. Hospitals will control the quantity of Veklury that they order, enabling them to have ample, predictable supply of Veklury in advance of any anticipated increase in COVID-19 incidence. (See link for article)
Source: Gilead Sciences, Inc.
Oh goody. Now public officials can reclaim their lost profits when Remdesivir bombed for Ebola.
Fauci has financial ties to new drugs that are being pushed through the pipeline as alleged remedies for the Wuhan coronavirus (covid-19), which explains his anomalous opposition to HCQ, which he once promoted.
Every doctor and medical professional who has bravely come forward in support of HCQ during the current pandemic, by the way, despite the deep state’s opposition to it, has faced ridicule and persecution.
Gilead was able to strongarm the federal government back in 2009 into buying up stocks of Tamiflu, enriching the pocketbooks of not just Rumsfeld but also George Schultz, a former U.S. secretary of state. Rumsfeld chaired Gilead while Schultz sat on the company’s board.
“The interesting part is, Gilead was part of the vaccine lobby at whose behest the WHO faked the H1N1 pandemic in 2009, and kept it a secret from people until committees were setup (sic) which exposed the entire racket,” reports Great Game India.
As a background, Gilead appears to be a creation of the military-industrial complex with a dark history of bioterrorism, according to Great Game India.
Despite its benign image as a mere pharmaceutical manufacturer, Gilead has been accused of engaging in illegal bioweapons research programs in the country of Georgia, where 73 people are said to have died at the hands of Gilead researchers who were testing deadly chemicals on them.
And public officials and the media wonder why the public no longer trusts government employees and their directives…..
Regarding trust, this just out today. See if you notice what’s wrong with it: https://www.medpagetoday.com/infectiousdisease/covid19/88912?xid=nl_covidupdate_2020-10-
A former FDA commissioner and a vaccine co-inventor told a House panel on Wednesday that they are confident in the FDA’s review process for vaccines…..
Please know our government has never come clean on vaccine injuries, not to mention has severe conflicts of interest by owning patents on them. https://madisonarealymesupportgroup.com/2020/09/11/examining-rfk-jr-s-claim-that-the-cdc-owns-over-20-vaccine-patents-its-actually-over-50/
And then the very loaded statement:
Pressure from the administration to approve drugs such as hydroxychloroquine and convalescent plasma through an EUA “without clear evidence of safety or efficacy” has created concern that “the same low standards” would apply to a vaccine, he said.
Meanwhile in reality, doctors worldwide are screaming that HCQ works clinically: https://madisonarealymesupportgroup.com/2020/06/16/aaps-sues-fda-for-irrational-interference-of-access-to-life-saving-hydroxychloroquine/
Fauci’s been accused of running a misinformation campaign against it: https://madisonarealymesupportgroup.com/2020/08/11/yale-epidemiologist-dr-fauci-running-misinformation-campaign-against-hydroxychloroquine-aap-says-fda-caused-20000-deaths/?
But even more importantly, these studies debunking HCQ have been found to be a scam: https://madisonarealymesupportgroup.com/2020/06/30/dr-meryl-nass-discovers-hydroxychloroquine-experiments-were-designed-to-kill-covid-patients-how-many-were-murdered/
Still, ‘crickets’ from public ‘authorities.’
Here’s the real clincher from Dr. Paul Offit, co-inventor of the rotavirus vaccine:
“If COVID-19 vaccines are released before they’re ready to be released, you will hear from these people, and … from people like Drs. Francis Collins and Tony Fauci who are trusted by the American public,” he said.